Oritavancin (Orbactiv): A New-Generation Lipoglycopeptide for the Treatment Of Acute Bacterial Skin and Skin Structure Infections.

Article Details

Citation

Copy to clipboard

Rosenthal S, Decano AG, Bandali A, Lai D, Malat GE, Bias TE

Oritavancin (Orbactiv): A New-Generation Lipoglycopeptide for the Treatment Of Acute Bacterial Skin and Skin Structure Infections.

P T. 2018 Mar;43(3):143-179.

PubMed ID

29491695 [ View in PubMed

]

Abstract

Oritavancin (Orbactiv): a new-generation lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections.

DrugBank Data that Cites this Article

Drugs

Oritavancin

Drug Enzymes

Drug	Enzyme	Kind	Organism	Pharmacological Action	Actions
Oritavancin	Cytochrome P450 2C9	Protein	Humans	Unknown	Inhibitor	Details